60% of Japanese prescriptions allow use of generic copies, JPA survey finds

8 December 2008

In Japan, the ratio of prescriptions in which physicians did not sign in the column saying "do not change to generic drugs" was 59.8% (numbering a total of 330,600), according to the interim results of a survey on the use of off-patent medicines - a practice that the government is encouraging in order to save on health spending - conducted by the Japan Pharmaceutical Association.

The results were presented by the JPA president Nobuo Yamamoto to the Chuikyo (the Central Social Health Insurance Medical Council).

The survey was conducted among 2,000 pharmacies throughout the country from September through October. The collection rate was 22.5% (450 pharmacies).

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight